" class="no-js "lang="en-US"> Bio-Rad Archives - Medtech Alert
Sunday, November 10, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Bio-Rad Launches CFX Duet Real-Time PCR System

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Bio-Rad Introduces Anti-Daratumumab Antibodies

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

Bio-Rad Launches its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics

Bio–Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic […]

Bio-Rad Launches IgA and IgM SARS-CoV-2 Bio-Plex Pro Immunoassay Panels to Study COVID-19 Antibody Response

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more